nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—SLC7A5—Melphalan—ovarian cancer	0.471	0.692	CbGbCtD
Levothyroxine—ABCB1—ovarian cancer	0.154	1	CbGaD
Levothyroxine—SLCO1A2—Chlorambucil—ovarian cancer	0.0713	0.105	CbGbCtD
Levothyroxine—SLCO1B3—Paclitaxel—ovarian cancer	0.0396	0.0582	CbGbCtD
Levothyroxine—SLCO1B3—Docetaxel—ovarian cancer	0.0286	0.0421	CbGbCtD
Levothyroxine—ABCB1—Topotecan—ovarian cancer	0.0133	0.0196	CbGbCtD
Levothyroxine—CYP2C8—Paclitaxel—ovarian cancer	0.00976	0.0143	CbGbCtD
Levothyroxine—ABCB1—Vinorelbine—ovarian cancer	0.00941	0.0138	CbGbCtD
Levothyroxine—CYP3A4—Topotecan—ovarian cancer	0.008	0.0118	CbGbCtD
Levothyroxine—ABCB1—Paclitaxel—ovarian cancer	0.00661	0.00971	CbGbCtD
Levothyroxine—CYP3A4—Vinorelbine—ovarian cancer	0.00564	0.00828	CbGbCtD
Levothyroxine—ABCB1—Docetaxel—ovarian cancer	0.00478	0.00702	CbGbCtD
Levothyroxine—CYP3A4—Paclitaxel—ovarian cancer	0.00396	0.00582	CbGbCtD
Levothyroxine—ABCB1—Doxorubicin—ovarian cancer	0.00356	0.00523	CbGbCtD
Levothyroxine—CYP3A4—Docetaxel—ovarian cancer	0.00286	0.00421	CbGbCtD
Levothyroxine—CYP3A4—Doxorubicin—ovarian cancer	0.00213	0.00314	CbGbCtD
Levothyroxine—SLC16A2—myometrium—ovarian cancer	0.00184	0.0316	CbGeAlD
Levothyroxine—SERPINA7—bone marrow—ovarian cancer	0.00181	0.0311	CbGeAlD
Levothyroxine—SLC7A5—myometrium—ovarian cancer	0.00155	0.0266	CbGeAlD
Levothyroxine—SLCO4C1—endometrium—ovarian cancer	0.00149	0.0256	CbGeAlD
Levothyroxine—TTR—embryo—ovarian cancer	0.00145	0.0249	CbGeAlD
Levothyroxine—SLC16A2—uterine cervix—ovarian cancer	0.00143	0.0246	CbGeAlD
Levothyroxine—SLCO4A1—myometrium—ovarian cancer	0.00135	0.0232	CbGeAlD
Levothyroxine—THRB—gonad—ovarian cancer	0.00132	0.0228	CbGeAlD
Levothyroxine—THRA—gonad—ovarian cancer	0.00132	0.0228	CbGeAlD
Levothyroxine—SLC16A2—endometrium—ovarian cancer	0.00129	0.0223	CbGeAlD
Levothyroxine—SLC7A5—epithelium—ovarian cancer	0.00122	0.0209	CbGeAlD
Levothyroxine—SLC7A5—uterine cervix—ovarian cancer	0.0012	0.0207	CbGeAlD
Levothyroxine—SLC16A2—uterus—ovarian cancer	0.00119	0.0205	CbGeAlD
Levothyroxine—THRA—female reproductive system—ovarian cancer	0.00118	0.0203	CbGeAlD
Levothyroxine—THRB—female reproductive system—ovarian cancer	0.00118	0.0203	CbGeAlD
Levothyroxine—SLCO4C1—bone marrow—ovarian cancer	0.00117	0.02	CbGeAlD
Levothyroxine—SLC7A5—decidua—ovarian cancer	0.00115	0.0197	CbGeAlD
Levothyroxine—SLCO4C1—vagina—ovarian cancer	0.00112	0.0192	CbGeAlD
Levothyroxine—SLC7A5—endometrium—ovarian cancer	0.00109	0.0187	CbGeAlD
Levothyroxine—SLCO1B3—vagina—ovarian cancer	0.00108	0.0187	CbGeAlD
Levothyroxine—THRB—female gonad—ovarian cancer	0.00108	0.0185	CbGeAlD
Levothyroxine—THRA—female gonad—ovarian cancer	0.00108	0.0185	CbGeAlD
Levothyroxine—THRB—vagina—ovarian cancer	0.00107	0.0184	CbGeAlD
Levothyroxine—SLC7A5—gonad—ovarian cancer	0.00101	0.0174	CbGeAlD
Levothyroxine—SLC7A5—uterus—ovarian cancer	0.001	0.0173	CbGeAlD
Levothyroxine—SLCO4A1—decidua—ovarian cancer	0.001	0.0172	CbGeAlD
Levothyroxine—SLC16A2—female gonad—ovarian cancer	0.000975	0.0168	CbGeAlD
Levothyroxine—SLC16A2—vagina—ovarian cancer	0.00097	0.0167	CbGeAlD
Levothyroxine—THRA—testis—ovarian cancer	0.000955	0.0164	CbGeAlD
Levothyroxine—THRB—testis—ovarian cancer	0.000955	0.0164	CbGeAlD
Levothyroxine—SLCO4A1—endometrium—ovarian cancer	0.000952	0.0164	CbGeAlD
Levothyroxine—SLC7A5—female reproductive system—ovarian cancer	0.000903	0.0155	CbGeAlD
Levothyroxine—TTR—female reproductive system—ovarian cancer	0.000879	0.0151	CbGeAlD
Levothyroxine—SLC16A2—testis—ovarian cancer	0.000865	0.0149	CbGeAlD
Levothyroxine—SLC7A5—bone marrow—ovarian cancer	0.000852	0.0147	CbGeAlD
Levothyroxine—TTR—bone marrow—ovarian cancer	0.00083	0.0143	CbGeAlD
Levothyroxine—SLC7A5—female gonad—ovarian cancer	0.000822	0.0141	CbGeAlD
Levothyroxine—SLC7A5—vagina—ovarian cancer	0.000817	0.014	CbGeAlD
Levothyroxine—SLCO1C1—testis—ovarian cancer	0.000794	0.0137	CbGeAlD
Levothyroxine—SLCO4A1—female reproductive system—ovarian cancer	0.000788	0.0136	CbGeAlD
Levothyroxine—SLC7A5—testis—ovarian cancer	0.000729	0.0125	CbGeAlD
Levothyroxine—SLCO4A1—vagina—ovarian cancer	0.000713	0.0123	CbGeAlD
Levothyroxine—TTR—testis—ovarian cancer	0.00071	0.0122	CbGeAlD
Levothyroxine—SLCO1B1—female reproductive system—ovarian cancer	0.000694	0.0119	CbGeAlD
Levothyroxine—THRA—lymph node—ovarian cancer	0.000692	0.0119	CbGeAlD
Levothyroxine—THRB—lymph node—ovarian cancer	0.000692	0.0119	CbGeAlD
Levothyroxine—SLCO4A1—testis—ovarian cancer	0.000636	0.0109	CbGeAlD
Levothyroxine—SLC16A2—lymph node—ovarian cancer	0.000627	0.0108	CbGeAlD
Levothyroxine—SLCO1C1—lymph node—ovarian cancer	0.000576	0.00989	CbGeAlD
Levothyroxine—SLC7A5—lymph node—ovarian cancer	0.000528	0.00908	CbGeAlD
Levothyroxine—Dysphagia—Vinorelbine—ovarian cancer	0.000481	0.00741	CcSEcCtD
Levothyroxine—Sweating—Topotecan—ovarian cancer	0.000481	0.0074	CcSEcCtD
Levothyroxine—CYP2C8—endometrium—ovarian cancer	0.000476	0.00819	CbGeAlD
Levothyroxine—Angina pectoris—Vinorelbine—ovarian cancer	0.000469	0.00721	CcSEcCtD
Levothyroxine—SLCO4A1—lymph node—ovarian cancer	0.000461	0.00793	CbGeAlD
Levothyroxine—SLCO1A2—testis—ovarian cancer	0.000456	0.00783	CbGeAlD
Levothyroxine—ALB—testis—ovarian cancer	0.000453	0.00779	CbGeAlD
Levothyroxine—Alopecia—Chlorambucil—ovarian cancer	0.000447	0.00688	CcSEcCtD
Levothyroxine—Weight decreased—Vinorelbine—ovarian cancer	0.000435	0.0067	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Vinorelbine—ovarian cancer	0.000423	0.00651	CcSEcCtD
Levothyroxine—Myocardial infarction—Vinorelbine—ovarian cancer	0.000421	0.00647	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Paclitaxel—ovarian cancer	0.000413	0.00636	CcSEcCtD
Levothyroxine—Tremor—Chlorambucil—ovarian cancer	0.000413	0.00635	CcSEcCtD
Levothyroxine—Flushing—Melphalan—ovarian cancer	0.000409	0.0063	CcSEcCtD
Levothyroxine—Agitation—Chlorambucil—ovarian cancer	0.000405	0.00623	CcSEcCtD
Levothyroxine—Angioedema—Chlorambucil—ovarian cancer	0.000402	0.00619	CcSEcCtD
Levothyroxine—Alopecia—Topotecan—ovarian cancer	0.000398	0.00612	CcSEcCtD
Levothyroxine—CYP2C8—female reproductive system—ovarian cancer	0.000394	0.00678	CbGeAlD
Levothyroxine—Arrhythmia—Melphalan—ovarian cancer	0.000394	0.00606	CcSEcCtD
Levothyroxine—Alopecia—Melphalan—ovarian cancer	0.00039	0.006	CcSEcCtD
Levothyroxine—Cardiac failure—Paclitaxel—ovarian cancer	0.000384	0.00591	CcSEcCtD
Levothyroxine—Hypoglycaemia—Paclitaxel—ovarian cancer	0.000384	0.00591	CcSEcCtD
Levothyroxine—Convulsion—Chlorambucil—ovarian cancer	0.000382	0.00587	CcSEcCtD
Levothyroxine—Confusional state—Chlorambucil—ovarian cancer	0.000362	0.00558	CcSEcCtD
Levothyroxine—Angioedema—Topotecan—ovarian cancer	0.000358	0.00551	CcSEcCtD
Levothyroxine—Flushing—Vinorelbine—ovarian cancer	0.000358	0.0055	CcSEcCtD
Levothyroxine—CYP2C8—vagina—ovarian cancer	0.000357	0.00613	CbGeAlD
Levothyroxine—Cardiac arrest—Paclitaxel—ovarian cancer	0.000356	0.00548	CcSEcCtD
Levothyroxine—Mood swings—Paclitaxel—ovarian cancer	0.000355	0.00546	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Docetaxel—ovarian cancer	0.00035	0.00539	CcSEcCtD
Levothyroxine—Dehydration—Paclitaxel—ovarian cancer	0.000348	0.00536	CcSEcCtD
Levothyroxine—Arrhythmia—Vinorelbine—ovarian cancer	0.000344	0.0053	CcSEcCtD
Levothyroxine—Alopecia—Vinorelbine—ovarian cancer	0.00034	0.00524	CcSEcCtD
Levothyroxine—Arthralgia—Topotecan—ovarian cancer	0.000334	0.00514	CcSEcCtD
Levothyroxine—Convulsion—Melphalan—ovarian cancer	0.000333	0.00512	CcSEcCtD
Levothyroxine—Muscular weakness—Paclitaxel—ovarian cancer	0.00033	0.00508	CcSEcCtD
Levothyroxine—ALB—lymph node—ovarian cancer	0.000328	0.00565	CbGeAlD
Levothyroxine—Cardiac failure—Docetaxel—ovarian cancer	0.000325	0.00501	CcSEcCtD
Levothyroxine—ABCB1—myometrium—ovarian cancer	0.000324	0.00558	CbGeAlD
Levothyroxine—Dysphagia—Paclitaxel—ovarian cancer	0.000324	0.00498	CcSEcCtD
Levothyroxine—CYP2C8—testis—ovarian cancer	0.000318	0.00547	CbGeAlD
Levothyroxine—Sweating increased—Paclitaxel—ovarian cancer	0.000315	0.00485	CcSEcCtD
Levothyroxine—ABCB1—embryo—ovarian cancer	0.000312	0.00536	CbGeAlD
Levothyroxine—Fatigue—Chlorambucil—ovarian cancer	0.00031	0.00477	CcSEcCtD
Levothyroxine—Hyperhidrosis—Topotecan—ovarian cancer	0.000309	0.00476	CcSEcCtD
Levothyroxine—Angioedema—Vinorelbine—ovarian cancer	0.000306	0.00472	CcSEcCtD
Levothyroxine—Tachycardia—Melphalan—ovarian cancer	0.000306	0.0047	CcSEcCtD
Levothyroxine—Palpitations—Vinorelbine—ovarian cancer	0.000296	0.00456	CcSEcCtD
Levothyroxine—Feeling abnormal—Chlorambucil—ovarian cancer	0.000296	0.00456	CcSEcCtD
Levothyroxine—Dehydration—Docetaxel—ovarian cancer	0.000295	0.00454	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000294	0.00452	CcSEcCtD
Levothyroxine—Weight decreased—Paclitaxel—ovarian cancer	0.000293	0.00451	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000291	0.00449	CcSEcCtD
Levothyroxine—Urticaria—Chlorambucil—ovarian cancer	0.000286	0.00439	CcSEcCtD
Levothyroxine—Arthralgia—Vinorelbine—ovarian cancer	0.000285	0.00439	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000285	0.00439	CcSEcCtD
Levothyroxine—Dyspnoea—Topotecan—ovarian cancer	0.000285	0.00439	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.000285	0.00438	CcSEcCtD
Levothyroxine—Abdominal pain—Chlorambucil—ovarian cancer	0.000284	0.00437	CcSEcCtD
Levothyroxine—Body temperature increased—Chlorambucil—ovarian cancer	0.000284	0.00437	CcSEcCtD
Levothyroxine—Myocardial infarction—Paclitaxel—ovarian cancer	0.000283	0.00435	CcSEcCtD
Levothyroxine—Dyspnoea—Melphalan—ovarian cancer	0.000279	0.0043	CcSEcCtD
Levothyroxine—Fatigue—Topotecan—ovarian cancer	0.000276	0.00424	CcSEcCtD
Levothyroxine—Dysphagia—Docetaxel—ovarian cancer	0.000274	0.00422	CcSEcCtD
Levothyroxine—Fatigue—Melphalan—ovarian cancer	0.00027	0.00416	CcSEcCtD
Levothyroxine—Coma—Epirubicin—ovarian cancer	0.00027	0.00415	CcSEcCtD
Levothyroxine—Angina pectoris—Docetaxel—ovarian cancer	0.000267	0.00411	CcSEcCtD
Levothyroxine—CYP3A4—female reproductive system—ovarian cancer	0.000267	0.00459	CbGeAlD
Levothyroxine—Tachycardia—Vinorelbine—ovarian cancer	0.000267	0.00411	CcSEcCtD
Levothyroxine—Feeling abnormal—Topotecan—ovarian cancer	0.000264	0.00406	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Topotecan—ovarian cancer	0.000262	0.00403	CcSEcCtD
Levothyroxine—Asthenia—Chlorambucil—ovarian cancer	0.000258	0.00397	CcSEcCtD
Levothyroxine—ABCB1—epithelium—ovarian cancer	0.000255	0.00438	CbGeAlD
Levothyroxine—Pruritus—Chlorambucil—ovarian cancer	0.000254	0.00391	CcSEcCtD
Levothyroxine—Urticaria—Topotecan—ovarian cancer	0.000254	0.00391	CcSEcCtD
Levothyroxine—Body temperature increased—Topotecan—ovarian cancer	0.000253	0.00389	CcSEcCtD
Levothyroxine—Abdominal pain—Topotecan—ovarian cancer	0.000253	0.00389	CcSEcCtD
Levothyroxine—ABCB1—uterine cervix—ovarian cancer	0.000252	0.00434	CbGeAlD
Levothyroxine—Coma—Doxorubicin—ovarian cancer	0.000249	0.00384	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000249	0.00384	CcSEcCtD
Levothyroxine—Urticaria—Melphalan—ovarian cancer	0.000249	0.00383	CcSEcCtD
Levothyroxine—Weight decreased—Docetaxel—ovarian cancer	0.000248	0.00382	CcSEcCtD
Levothyroxine—Liotrix—ABCB1—ovarian cancer	0.000246	0.578	CrCbGaD
Levothyroxine—Diarrhoea—Chlorambucil—ovarian cancer	0.000246	0.00378	CcSEcCtD
Levothyroxine—Dyspnoea—Vinorelbine—ovarian cancer	0.000244	0.00375	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000241	0.00371	CcSEcCtD
Levothyroxine—ABCB1—decidua—ovarian cancer	0.00024	0.00413	CbGeAlD
Levothyroxine—Flushing—Paclitaxel—ovarian cancer	0.00024	0.0037	CcSEcCtD
Levothyroxine—Myocardial infarction—Docetaxel—ovarian cancer	0.00024	0.00369	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Epirubicin—ovarian cancer	0.000236	0.00363	CcSEcCtD
Levothyroxine—Fatigue—Vinorelbine—ovarian cancer	0.000236	0.00363	CcSEcCtD
Levothyroxine—Arrhythmia—Paclitaxel—ovarian cancer	0.000231	0.00356	CcSEcCtD
Levothyroxine—Asthenia—Topotecan—ovarian cancer	0.00023	0.00353	CcSEcCtD
Levothyroxine—Alopecia—Paclitaxel—ovarian cancer	0.000229	0.00352	CcSEcCtD
Levothyroxine—Vomiting—Chlorambucil—ovarian cancer	0.000229	0.00352	CcSEcCtD
Levothyroxine—ABCB1—endometrium—ovarian cancer	0.000228	0.00393	CbGeAlD
Levothyroxine—Increased appetite—Epirubicin—ovarian cancer	0.000228	0.00351	CcSEcCtD
Levothyroxine—Pruritus—Topotecan—ovarian cancer	0.000226	0.00348	CcSEcCtD
Levothyroxine—Feeling abnormal—Vinorelbine—ovarian cancer	0.000226	0.00347	CcSEcCtD
Levothyroxine—Asthenia—Melphalan—ovarian cancer	0.000225	0.00346	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000224	0.00344	CcSEcCtD
Levothyroxine—Pruritus—Melphalan—ovarian cancer	0.000222	0.00341	CcSEcCtD
Levothyroxine—Tension—Paclitaxel—ovarian cancer	0.000221	0.00341	CcSEcCtD
Levothyroxine—Hypoglycaemia—Epirubicin—ovarian cancer	0.000219	0.00338	CcSEcCtD
Levothyroxine—Cardiac failure—Epirubicin—ovarian cancer	0.000219	0.00338	CcSEcCtD
Levothyroxine—Nervousness—Paclitaxel—ovarian cancer	0.000219	0.00337	CcSEcCtD
Levothyroxine—Diarrhoea—Topotecan—ovarian cancer	0.000219	0.00337	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.000218	0.00336	CcSEcCtD
Levothyroxine—Urticaria—Vinorelbine—ovarian cancer	0.000217	0.00335	CcSEcCtD
Levothyroxine—Abdominal pain—Vinorelbine—ovarian cancer	0.000216	0.00333	CcSEcCtD
Levothyroxine—Body temperature increased—Vinorelbine—ovarian cancer	0.000216	0.00333	CcSEcCtD
Levothyroxine—Diarrhoea—Melphalan—ovarian cancer	0.000214	0.0033	CcSEcCtD
Levothyroxine—Nausea—Chlorambucil—ovarian cancer	0.000213	0.00328	CcSEcCtD
Levothyroxine—ABCB1—gonad—ovarian cancer	0.000212	0.00364	CbGeAlD
Levothyroxine—Tremor—Paclitaxel—ovarian cancer	0.000211	0.00325	CcSEcCtD
Levothyroxine—Increased appetite—Doxorubicin—ovarian cancer	0.000211	0.00325	CcSEcCtD
Levothyroxine—Affect lability—Epirubicin—ovarian cancer	0.000211	0.00324	CcSEcCtD
Levothyroxine—ABCB1—uterus—ovarian cancer	0.00021	0.00362	CbGeAlD
Levothyroxine—Agitation—Paclitaxel—ovarian cancer	0.000207	0.00319	CcSEcCtD
Levothyroxine—Angioedema—Paclitaxel—ovarian cancer	0.000206	0.00317	CcSEcCtD
Levothyroxine—Flushing—Docetaxel—ovarian cancer	0.000204	0.00314	CcSEcCtD
Levothyroxine—Cardiac arrest—Epirubicin—ovarian cancer	0.000204	0.00313	CcSEcCtD
Levothyroxine—Vomiting—Topotecan—ovarian cancer	0.000203	0.00313	CcSEcCtD
Levothyroxine—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000203	0.00312	CcSEcCtD
Levothyroxine—Cardiac failure—Doxorubicin—ovarian cancer	0.000203	0.00312	CcSEcCtD
Levothyroxine—Mood swings—Epirubicin—ovarian cancer	0.000203	0.00312	CcSEcCtD
Levothyroxine—Rash—Topotecan—ovarian cancer	0.000202	0.0031	CcSEcCtD
Levothyroxine—Dermatitis—Topotecan—ovarian cancer	0.000202	0.0031	CcSEcCtD
Levothyroxine—Headache—Topotecan—ovarian cancer	0.0002	0.00308	CcSEcCtD
Levothyroxine—Palpitations—Paclitaxel—ovarian cancer	0.000199	0.00307	CcSEcCtD
Levothyroxine—Vomiting—Melphalan—ovarian cancer	0.000199	0.00306	CcSEcCtD
Levothyroxine—Dehydration—Epirubicin—ovarian cancer	0.000199	0.00306	CcSEcCtD
Levothyroxine—Rash—Melphalan—ovarian cancer	0.000198	0.00304	CcSEcCtD
Levothyroxine—Dermatitis—Melphalan—ovarian cancer	0.000197	0.00304	CcSEcCtD
Levothyroxine—Asthenia—Vinorelbine—ovarian cancer	0.000196	0.00302	CcSEcCtD
Levothyroxine—Arrhythmia—Docetaxel—ovarian cancer	0.000196	0.00302	CcSEcCtD
Levothyroxine—Convulsion—Paclitaxel—ovarian cancer	0.000195	0.00301	CcSEcCtD
Levothyroxine—Affect lability—Doxorubicin—ovarian cancer	0.000195	0.003	CcSEcCtD
Levothyroxine—Alopecia—Docetaxel—ovarian cancer	0.000194	0.00299	CcSEcCtD
Levothyroxine—Pruritus—Vinorelbine—ovarian cancer	0.000194	0.00298	CcSEcCtD
Levothyroxine—Arthralgia—Paclitaxel—ovarian cancer	0.000192	0.00295	CcSEcCtD
Levothyroxine—Anxiety—Paclitaxel—ovarian cancer	0.000191	0.00294	CcSEcCtD
Levothyroxine—Nausea—Topotecan—ovarian cancer	0.00019	0.00292	CcSEcCtD
Levothyroxine—ABCB1—female reproductive system—ovarian cancer	0.000189	0.00325	CbGeAlD
Levothyroxine—Muscular weakness—Epirubicin—ovarian cancer	0.000189	0.00291	CcSEcCtD
Levothyroxine—Cardiac arrest—Doxorubicin—ovarian cancer	0.000188	0.0029	CcSEcCtD
Levothyroxine—Mood swings—Doxorubicin—ovarian cancer	0.000188	0.00289	CcSEcCtD
Levothyroxine—Diarrhoea—Vinorelbine—ovarian cancer	0.000187	0.00288	CcSEcCtD
Levothyroxine—Nausea—Melphalan—ovarian cancer	0.000186	0.00286	CcSEcCtD
Levothyroxine—Confusional state—Paclitaxel—ovarian cancer	0.000186	0.00286	CcSEcCtD
Levothyroxine—Dysphagia—Epirubicin—ovarian cancer	0.000185	0.00285	CcSEcCtD
Levothyroxine—Dehydration—Doxorubicin—ovarian cancer	0.000184	0.00284	CcSEcCtD
Levothyroxine—Shock—Paclitaxel—ovarian cancer	0.000181	0.00279	CcSEcCtD
Levothyroxine—Angina pectoris—Epirubicin—ovarian cancer	0.00018	0.00277	CcSEcCtD
Levothyroxine—Liothyronine—ABCB1—ovarian cancer	0.00018	0.422	CrCbGaD
Levothyroxine—Tachycardia—Paclitaxel—ovarian cancer	0.00018	0.00276	CcSEcCtD
Levothyroxine—ABCB1—bone marrow—ovarian cancer	0.000179	0.00307	CbGeAlD
Levothyroxine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000178	0.00274	CcSEcCtD
Levothyroxine—Muscular weakness—Doxorubicin—ovarian cancer	0.000175	0.00269	CcSEcCtD
Levothyroxine—Vomiting—Vinorelbine—ovarian cancer	0.000174	0.00268	CcSEcCtD
Levothyroxine—Rash—Vinorelbine—ovarian cancer	0.000173	0.00266	CcSEcCtD
Levothyroxine—Dermatitis—Vinorelbine—ovarian cancer	0.000172	0.00265	CcSEcCtD
Levothyroxine—ABCB1—female gonad—ovarian cancer	0.000172	0.00296	CbGeAlD
Levothyroxine—Headache—Vinorelbine—ovarian cancer	0.000171	0.00264	CcSEcCtD
Levothyroxine—Dysphagia—Doxorubicin—ovarian cancer	0.000171	0.00264	CcSEcCtD
Levothyroxine—ABCB1—vagina—ovarian cancer	0.000171	0.00294	CbGeAlD
Levothyroxine—Palpitations—Docetaxel—ovarian cancer	0.000169	0.0026	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000168	0.00258	CcSEcCtD
Levothyroxine—Weight decreased—Epirubicin—ovarian cancer	0.000167	0.00258	CcSEcCtD
Levothyroxine—Angina pectoris—Doxorubicin—ovarian cancer	0.000167	0.00257	CcSEcCtD
Levothyroxine—Insomnia—Paclitaxel—ovarian cancer	0.000166	0.00256	CcSEcCtD
Levothyroxine—Convulsion—Docetaxel—ovarian cancer	0.000166	0.00255	CcSEcCtD
Levothyroxine—Dyspnoea—Paclitaxel—ovarian cancer	0.000164	0.00253	CcSEcCtD
Levothyroxine—Arthralgia—Docetaxel—ovarian cancer	0.000163	0.0025	CcSEcCtD
Levothyroxine—Nausea—Vinorelbine—ovarian cancer	0.000163	0.0025	CcSEcCtD
Levothyroxine—Fatigue—Paclitaxel—ovarian cancer	0.000159	0.00244	CcSEcCtD
Levothyroxine—Sweating—Epirubicin—ovarian cancer	0.000158	0.00243	CcSEcCtD
Levothyroxine—Confusional state—Docetaxel—ovarian cancer	0.000157	0.00242	CcSEcCtD
Levothyroxine—Weight decreased—Doxorubicin—ovarian cancer	0.000155	0.00238	CcSEcCtD
Levothyroxine—Shock—Docetaxel—ovarian cancer	0.000154	0.00236	CcSEcCtD
Levothyroxine—ABCB1—testis—ovarian cancer	0.000153	0.00262	CbGeAlD
Levothyroxine—Tachycardia—Docetaxel—ovarian cancer	0.000152	0.00234	CcSEcCtD
Levothyroxine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000152	0.00233	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000151	0.00232	CcSEcCtD
Levothyroxine—Sweating—Doxorubicin—ovarian cancer	0.000146	0.00225	CcSEcCtD
Levothyroxine—Urticaria—Paclitaxel—ovarian cancer	0.000146	0.00225	CcSEcCtD
Levothyroxine—Abdominal pain—Paclitaxel—ovarian cancer	0.000146	0.00224	CcSEcCtD
Levothyroxine—Body temperature increased—Paclitaxel—ovarian cancer	0.000146	0.00224	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000142	0.00219	CcSEcCtD
Levothyroxine—Insomnia—Docetaxel—ovarian cancer	0.000141	0.00217	CcSEcCtD
Levothyroxine—Dyspnoea—Docetaxel—ovarian cancer	0.000139	0.00214	CcSEcCtD
Levothyroxine—Flushing—Epirubicin—ovarian cancer	0.000137	0.00212	CcSEcCtD
Levothyroxine—Fatigue—Docetaxel—ovarian cancer	0.000135	0.00207	CcSEcCtD
Levothyroxine—Arrhythmia—Epirubicin—ovarian cancer	0.000132	0.00204	CcSEcCtD
Levothyroxine—Asthenia—Paclitaxel—ovarian cancer	0.000132	0.00203	CcSEcCtD
Levothyroxine—Alopecia—Epirubicin—ovarian cancer	0.000131	0.00201	CcSEcCtD
Levothyroxine—Pruritus—Paclitaxel—ovarian cancer	0.00013	0.002	CcSEcCtD
Levothyroxine—Feeling abnormal—Docetaxel—ovarian cancer	0.000129	0.00198	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000128	0.00196	CcSEcCtD
Levothyroxine—Flushing—Doxorubicin—ovarian cancer	0.000127	0.00196	CcSEcCtD
Levothyroxine—Tension—Epirubicin—ovarian cancer	0.000127	0.00195	CcSEcCtD
Levothyroxine—Diarrhoea—Paclitaxel—ovarian cancer	0.000126	0.00194	CcSEcCtD
Levothyroxine—Nervousness—Epirubicin—ovarian cancer	0.000125	0.00193	CcSEcCtD
Levothyroxine—Abdominal pain—Docetaxel—ovarian cancer	0.000123	0.0019	CcSEcCtD
Levothyroxine—Body temperature increased—Docetaxel—ovarian cancer	0.000123	0.0019	CcSEcCtD
Levothyroxine—Arrhythmia—Doxorubicin—ovarian cancer	0.000122	0.00188	CcSEcCtD
Levothyroxine—Alopecia—Doxorubicin—ovarian cancer	0.000121	0.00186	CcSEcCtD
Levothyroxine—Agitation—Epirubicin—ovarian cancer	0.000119	0.00182	CcSEcCtD
Levothyroxine—Tension—Doxorubicin—ovarian cancer	0.000117	0.0018	CcSEcCtD
Levothyroxine—Vomiting—Paclitaxel—ovarian cancer	0.000117	0.0018	CcSEcCtD
Levothyroxine—Rash—Paclitaxel—ovarian cancer	0.000116	0.00179	CcSEcCtD
Levothyroxine—Dermatitis—Paclitaxel—ovarian cancer	0.000116	0.00178	CcSEcCtD
Levothyroxine—Nervousness—Doxorubicin—ovarian cancer	0.000116	0.00178	CcSEcCtD
Levothyroxine—Headache—Paclitaxel—ovarian cancer	0.000115	0.00177	CcSEcCtD
Levothyroxine—Palpitations—Epirubicin—ovarian cancer	0.000114	0.00175	CcSEcCtD
Levothyroxine—Asthenia—Docetaxel—ovarian cancer	0.000112	0.00172	CcSEcCtD
Levothyroxine—Convulsion—Epirubicin—ovarian cancer	0.000112	0.00172	CcSEcCtD
Levothyroxine—ABCB1—lymph node—ovarian cancer	0.000111	0.0019	CbGeAlD
Levothyroxine—Pruritus—Docetaxel—ovarian cancer	0.00011	0.0017	CcSEcCtD
Levothyroxine—Arthralgia—Epirubicin—ovarian cancer	0.00011	0.00169	CcSEcCtD
Levothyroxine—Agitation—Doxorubicin—ovarian cancer	0.00011	0.00169	CcSEcCtD
Levothyroxine—Anxiety—Epirubicin—ovarian cancer	0.000109	0.00168	CcSEcCtD
Levothyroxine—Nausea—Paclitaxel—ovarian cancer	0.000109	0.00168	CcSEcCtD
Levothyroxine—Diarrhoea—Docetaxel—ovarian cancer	0.000107	0.00164	CcSEcCtD
Levothyroxine—Confusional state—Epirubicin—ovarian cancer	0.000106	0.00163	CcSEcCtD
Levothyroxine—Palpitations—Doxorubicin—ovarian cancer	0.000105	0.00162	CcSEcCtD
Levothyroxine—Shock—Epirubicin—ovarian cancer	0.000104	0.00159	CcSEcCtD
Levothyroxine—Convulsion—Doxorubicin—ovarian cancer	0.000103	0.00159	CcSEcCtD
Levothyroxine—Tachycardia—Epirubicin—ovarian cancer	0.000103	0.00158	CcSEcCtD
Levothyroxine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000102	0.00157	CcSEcCtD
Levothyroxine—Arthralgia—Doxorubicin—ovarian cancer	0.000102	0.00156	CcSEcCtD
Levothyroxine—Anxiety—Doxorubicin—ovarian cancer	0.000101	0.00156	CcSEcCtD
Levothyroxine—Vomiting—Docetaxel—ovarian cancer	9.92e-05	0.00153	CcSEcCtD
Levothyroxine—Rash—Docetaxel—ovarian cancer	9.84e-05	0.00151	CcSEcCtD
Levothyroxine—Dermatitis—Docetaxel—ovarian cancer	9.83e-05	0.00151	CcSEcCtD
Levothyroxine—Confusional state—Doxorubicin—ovarian cancer	9.82e-05	0.00151	CcSEcCtD
Levothyroxine—Headache—Docetaxel—ovarian cancer	9.77e-05	0.0015	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	9.59e-05	0.00148	CcSEcCtD
Levothyroxine—Shock—Doxorubicin—ovarian cancer	9.58e-05	0.00147	CcSEcCtD
Levothyroxine—Insomnia—Epirubicin—ovarian cancer	9.52e-05	0.00146	CcSEcCtD
Levothyroxine—Tachycardia—Doxorubicin—ovarian cancer	9.5e-05	0.00146	CcSEcCtD
Levothyroxine—Hyperhidrosis—Doxorubicin—ovarian cancer	9.41e-05	0.00145	CcSEcCtD
Levothyroxine—Dyspnoea—Epirubicin—ovarian cancer	9.38e-05	0.00144	CcSEcCtD
Levothyroxine—Nausea—Docetaxel—ovarian cancer	9.27e-05	0.00143	CcSEcCtD
Levothyroxine—Fatigue—Epirubicin—ovarian cancer	9.07e-05	0.0014	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	8.87e-05	0.00137	CcSEcCtD
Levothyroxine—Insomnia—Doxorubicin—ovarian cancer	8.81e-05	0.00136	CcSEcCtD
Levothyroxine—Dyspnoea—Doxorubicin—ovarian cancer	8.68e-05	0.00134	CcSEcCtD
Levothyroxine—Feeling abnormal—Epirubicin—ovarian cancer	8.67e-05	0.00133	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Epirubicin—ovarian cancer	8.61e-05	0.00132	CcSEcCtD
Levothyroxine—Fatigue—Doxorubicin—ovarian cancer	8.4e-05	0.00129	CcSEcCtD
Levothyroxine—Urticaria—Epirubicin—ovarian cancer	8.36e-05	0.00129	CcSEcCtD
Levothyroxine—Abdominal pain—Epirubicin—ovarian cancer	8.32e-05	0.00128	CcSEcCtD
Levothyroxine—Body temperature increased—Epirubicin—ovarian cancer	8.32e-05	0.00128	CcSEcCtD
Levothyroxine—Feeling abnormal—Doxorubicin—ovarian cancer	8.02e-05	0.00123	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Doxorubicin—ovarian cancer	7.96e-05	0.00123	CcSEcCtD
Levothyroxine—Urticaria—Doxorubicin—ovarian cancer	7.74e-05	0.00119	CcSEcCtD
Levothyroxine—Abdominal pain—Doxorubicin—ovarian cancer	7.7e-05	0.00118	CcSEcCtD
Levothyroxine—Body temperature increased—Doxorubicin—ovarian cancer	7.7e-05	0.00118	CcSEcCtD
Levothyroxine—Asthenia—Epirubicin—ovarian cancer	7.55e-05	0.00116	CcSEcCtD
Levothyroxine—Pruritus—Epirubicin—ovarian cancer	7.45e-05	0.00115	CcSEcCtD
Levothyroxine—Diarrhoea—Epirubicin—ovarian cancer	7.2e-05	0.00111	CcSEcCtD
Levothyroxine—Asthenia—Doxorubicin—ovarian cancer	6.99e-05	0.00108	CcSEcCtD
Levothyroxine—Pruritus—Doxorubicin—ovarian cancer	6.89e-05	0.00106	CcSEcCtD
Levothyroxine—Vomiting—Epirubicin—ovarian cancer	6.69e-05	0.00103	CcSEcCtD
Levothyroxine—Diarrhoea—Doxorubicin—ovarian cancer	6.66e-05	0.00103	CcSEcCtD
Levothyroxine—Rash—Epirubicin—ovarian cancer	6.64e-05	0.00102	CcSEcCtD
Levothyroxine—Dermatitis—Epirubicin—ovarian cancer	6.63e-05	0.00102	CcSEcCtD
Levothyroxine—Headache—Epirubicin—ovarian cancer	6.59e-05	0.00101	CcSEcCtD
Levothyroxine—Nausea—Epirubicin—ovarian cancer	6.25e-05	0.000962	CcSEcCtD
Levothyroxine—Vomiting—Doxorubicin—ovarian cancer	6.19e-05	0.000953	CcSEcCtD
Levothyroxine—Rash—Doxorubicin—ovarian cancer	6.14e-05	0.000945	CcSEcCtD
Levothyroxine—Dermatitis—Doxorubicin—ovarian cancer	6.13e-05	0.000944	CcSEcCtD
Levothyroxine—Headache—Doxorubicin—ovarian cancer	6.1e-05	0.000939	CcSEcCtD
Levothyroxine—Nausea—Doxorubicin—ovarian cancer	5.78e-05	0.00089	CcSEcCtD
Levothyroxine—SLCO1B3—Metabolism—FASN—ovarian cancer	1.92e-05	0.000457	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	1.9e-05	0.000454	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—SLC5A5—ovarian cancer	1.88e-05	0.00045	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—AKT1—ovarian cancer	1.88e-05	0.000448	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	1.87e-05	0.000447	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—YAP1—ovarian cancer	1.85e-05	0.000441	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.83e-05	0.000436	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—SLC2A1—ovarian cancer	1.82e-05	0.000434	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.78e-05	0.000425	CbGpPWpGaD
Levothyroxine—TTR—Disease—PIK3CD—ovarian cancer	1.76e-05	0.000419	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CYP1B1—ovarian cancer	1.75e-05	0.000416	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.72e-05	0.000409	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—MAPK3—ovarian cancer	1.71e-05	0.000408	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—MAPK3—ovarian cancer	1.71e-05	0.000408	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.67e-05	0.000399	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	1.67e-05	0.000399	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—MYC—ovarian cancer	1.66e-05	0.000396	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—MYC—ovarian cancer	1.66e-05	0.000396	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.66e-05	0.000396	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TERT—ovarian cancer	1.66e-05	0.000396	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.65e-05	0.000394	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	1.64e-05	0.000392	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.61e-05	0.000383	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—YAP1—ovarian cancer	1.58e-05	0.000377	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.56e-05	0.000373	CbGpPWpGaD
Levothyroxine—TTR—Disease—ERBB2—ovarian cancer	1.55e-05	0.00037	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYTB—ovarian cancer	1.55e-05	0.000369	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PPP2R1A—ovarian cancer	1.55e-05	0.000369	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.54e-05	0.000369	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.54e-05	0.000367	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYTB—ovarian cancer	1.54e-05	0.000367	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CAV1—ovarian cancer	1.54e-05	0.000366	CbGpPWpGaD
Levothyroxine—TTR—Disease—PIK3CB—ovarian cancer	1.53e-05	0.000365	CbGpPWpGaD
Levothyroxine—TTR—Disease—MTOR—ovarian cancer	1.53e-05	0.000365	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.51e-05	0.000361	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—FASN—ovarian cancer	1.51e-05	0.000359	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.5e-05	0.000359	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.49e-05	0.000356	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—SLC5A5—ovarian cancer	1.48e-05	0.000353	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ESR1—ovarian cancer	1.48e-05	0.000353	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—SOD1—ovarian cancer	1.47e-05	0.000351	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PPP2R1A—ovarian cancer	1.47e-05	0.00035	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	1.46e-05	0.000348	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL6ST—ovarian cancer	1.46e-05	0.000347	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.45e-05	0.000347	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ABCB1—ovarian cancer	1.44e-05	0.000343	CbGpPWpGaD
Levothyroxine—TTR—Disease—CDKN1B—ovarian cancer	1.44e-05	0.000343	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—SLC2A1—ovarian cancer	1.43e-05	0.000341	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—TYMS—ovarian cancer	1.41e-05	0.000337	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.4e-05	0.000334	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CG—ovarian cancer	1.4e-05	0.000334	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—APC—ovarian cancer	1.4e-05	0.000334	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.37e-05	0.000328	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CYP1B1—ovarian cancer	1.37e-05	0.000327	CbGpPWpGaD
Levothyroxine—TTR—Disease—CTNNB1—ovarian cancer	1.36e-05	0.000324	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.35e-05	0.000323	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—BRIP1—ovarian cancer	1.35e-05	0.000323	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PPP1CC—ovarian cancer	1.35e-05	0.000323	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYTB—ovarian cancer	1.35e-05	0.000322	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.35e-05	0.000321	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—BRIP1—ovarian cancer	1.35e-05	0.000321	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PPP1CC—ovarian cancer	1.35e-05	0.000321	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	1.34e-05	0.000319	CbGpPWpGaD
Levothyroxine—TTR—Disease—PTEN—ovarian cancer	1.32e-05	0.000316	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.32e-05	0.000315	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.31e-05	0.000312	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NME2—ovarian cancer	1.29e-05	0.000308	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—FASN—ovarian cancer	1.29e-05	0.000307	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.29e-05	0.000307	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.27e-05	0.000304	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	1.27e-05	0.000302	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.24e-05	0.000296	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CD—ovarian cancer	1.23e-05	0.000293	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	1.22e-05	0.000292	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PPP2R1A—ovarian cancer	1.22e-05	0.00029	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.21e-05	0.000289	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.2e-05	0.000286	CbGpPWpGaD
Levothyroxine—TTR—Disease—STAT3—ovarian cancer	1.18e-05	0.000282	CbGpPWpGaD
Levothyroxine—TTR—Disease—NRAS—ovarian cancer	1.18e-05	0.000282	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.18e-05	0.000281	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—BRIP1—ovarian cancer	1.18e-05	0.000281	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.18e-05	0.000281	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	1.17e-05	0.00028	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—AKT1—ovarian cancer	1.15e-05	0.000275	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—AKT1—ovarian cancer	1.15e-05	0.000275	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	1.14e-05	0.000272	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CAV1—ovarian cancer	1.14e-05	0.000271	CbGpPWpGaD
Levothyroxine—TTR—Disease—MAPK3—ovarian cancer	1.13e-05	0.00027	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ABCB1—ovarian cancer	1.13e-05	0.000269	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.12e-05	0.000267	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—TYMS—ovarian cancer	1.11e-05	0.000265	CbGpPWpGaD
Levothyroxine—TTR—Disease—MYC—ovarian cancer	1.1e-05	0.000262	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.09e-05	0.000259	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ERBB2—ovarian cancer	1.09e-05	0.000259	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—CAV1—ovarian cancer	1.08e-05	0.000257	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	1.08e-05	0.000257	CbGpPWpGaD
Levothyroxine—TTR—Disease—MAPK1—ovarian cancer	1.08e-05	0.000257	CbGpPWpGaD
Levothyroxine—TTR—Disease—EGFR—ovarian cancer	1.08e-05	0.000257	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CB—ovarian cancer	1.07e-05	0.000256	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MTOR—ovarian cancer	1.07e-05	0.000256	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.06e-05	0.000253	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	1.04e-05	0.000248	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CG—ovarian cancer	1.04e-05	0.000247	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.03e-05	0.000247	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.03e-05	0.000246	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CXCL8—ovarian cancer	1.03e-05	0.000246	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1.02e-05	0.000244	CbGpPWpGaD
Levothyroxine—TTR—Disease—KRAS—ovarian cancer	1.02e-05	0.000242	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.01e-05	0.000241	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.01e-05	0.000241	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CDKN1B—ovarian cancer	1.01e-05	0.00024	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.86e-06	0.000235	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CASP3—ovarian cancer	9.86e-06	0.000235	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL2—ovarian cancer	9.84e-06	0.000235	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CG—ovarian cancer	9.81e-06	0.000234	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.8e-06	0.000234	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ABCB1—ovarian cancer	9.66e-06	0.00023	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCND1—ovarian cancer	9.6e-06	0.000229	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	9.53e-06	0.000227	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CTNNB1—ovarian cancer	9.5e-06	0.000227	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—TYMS—ovarian cancer	9.48e-06	0.000226	CbGpPWpGaD
Levothyroxine—TTR—Disease—PIK3CA—ovarian cancer	9.33e-06	0.000223	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MMP9—ovarian cancer	9.32e-06	0.000222	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PTEN—ovarian cancer	9.26e-06	0.000221	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CD—ovarian cancer	9.11e-06	0.000217	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—YAP1—ovarian cancer	9.08e-06	0.000217	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—YAP1—ovarian cancer	9.02e-06	0.000215	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.98e-06	0.000214	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CAV1—ovarian cancer	8.94e-06	0.000213	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.93e-06	0.000213	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	8.89e-06	0.000212	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	8.75e-06	0.000209	CbGpPWpGaD
Levothyroxine—TTR—Disease—HRAS—ovarian cancer	8.63e-06	0.000206	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CD—ovarian cancer	8.62e-06	0.000206	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.54e-06	0.000204	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	8.47e-06	0.000202	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—VEGFA—ovarian cancer	8.37e-06	0.0002	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYTB—ovarian cancer	8.31e-06	0.000198	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—STAT3—ovarian cancer	8.28e-06	0.000198	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NRAS—ovarian cancer	8.26e-06	0.000197	CbGpPWpGaD
Levothyroxine—TTR—Disease—IL6—ovarian cancer	8.26e-06	0.000197	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	8.14e-06	0.000194	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CB—ovarian cancer	7.94e-06	0.000189	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MAPK3—ovarian cancer	7.91e-06	0.000189	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—YAP1—ovarian cancer	7.91e-06	0.000189	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.9e-06	0.000188	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.85e-06	0.000187	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MYC—ovarian cancer	7.7e-06	0.000184	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CAV1—ovarian cancer	7.64e-06	0.000182	CbGpPWpGaD
Levothyroxine—TTR—Disease—AKT1—ovarian cancer	7.62e-06	0.000182	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MAPK1—ovarian cancer	7.53e-06	0.00018	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EGFR—ovarian cancer	7.53e-06	0.00018	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CB—ovarian cancer	7.52e-06	0.000179	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—FASN—ovarian cancer	7.4e-06	0.000176	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—FASN—ovarian cancer	7.36e-06	0.000175	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.3e-06	0.000174	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SLC5A5—ovarian cancer	7.28e-06	0.000174	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.26e-06	0.000173	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.26e-06	0.000173	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	7.26e-06	0.000173	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SLC5A5—ovarian cancer	7.24e-06	0.000173	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	7.16e-06	0.000171	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.15e-06	0.000171	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KRAS—ovarian cancer	7.11e-06	0.00017	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SLC2A1—ovarian cancer	7.03e-06	0.000168	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SLC2A1—ovarian cancer	6.99e-06	0.000167	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	6.96e-06	0.000166	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IL2—ovarian cancer	6.9e-06	0.000165	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.88e-06	0.000164	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTEN—ovarian cancer	6.86e-06	0.000164	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.84e-06	0.000163	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP1B1—ovarian cancer	6.74e-06	0.000161	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP1B1—ovarian cancer	6.7e-06	0.00016	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CA—ovarian cancer	6.53e-06	0.000156	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—FASN—ovarian cancer	6.45e-06	0.000154	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.34e-06	0.000151	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TP53—ovarian cancer	6.32e-06	0.000151	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	6.24e-06	0.000149	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.12e-06	0.000146	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	6.12e-06	0.000146	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HRAS—ovarian cancer	6.05e-06	0.000144	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	5.98e-06	0.000143	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.95e-06	0.000142	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PPP2R1A—ovarian cancer	5.94e-06	0.000142	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.91e-06	0.000141	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP1B1—ovarian cancer	5.87e-06	0.00014	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—VEGFA—ovarian cancer	5.87e-06	0.00014	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—NRAS—ovarian cancer	5.79e-06	0.000138	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL6—ovarian cancer	5.79e-06	0.000138	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MAPK3—ovarian cancer	5.55e-06	0.000132	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ABCB1—ovarian cancer	5.55e-06	0.000132	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ABCB1—ovarian cancer	5.52e-06	0.000132	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—TYMS—ovarian cancer	5.45e-06	0.00013	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—TYMS—ovarian cancer	5.42e-06	0.000129	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTEN—ovarian cancer	5.39e-06	0.000129	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—AKT1—ovarian cancer	5.34e-06	0.000127	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	5.33e-06	0.000127	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MAPK1—ovarian cancer	5.28e-06	0.000126	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.21e-06	0.000124	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—KRAS—ovarian cancer	4.99e-06	0.000119	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—YAP1—ovarian cancer	4.87e-06	0.000116	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CA—ovarian cancer	4.84e-06	0.000115	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—TYMS—ovarian cancer	4.75e-06	0.000113	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTEN—ovarian cancer	4.61e-06	0.00011	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CA—ovarian cancer	4.58e-06	0.000109	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TP53—ovarian cancer	4.43e-06	0.000106	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CAV1—ovarian cancer	4.39e-06	0.000105	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CAV1—ovarian cancer	4.37e-06	0.000104	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—HRAS—ovarian cancer	4.24e-06	0.000101	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.2e-06	0.0001	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.17e-06	9.95e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CG—ovarian cancer	4e-06	9.54e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CG—ovarian cancer	3.98e-06	9.49e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—FASN—ovarian cancer	3.97e-06	9.47e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—AKT1—ovarian cancer	3.95e-06	9.43e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.91e-06	9.32e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CAV1—ovarian cancer	3.83e-06	9.13e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	3.8e-06	9.07e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.77e-06	9e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—AKT1—ovarian cancer	3.74e-06	8.93e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.62e-06	8.63e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CD—ovarian cancer	3.52e-06	8.39e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CD—ovarian cancer	3.5e-06	8.34e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.48e-06	8.31e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	3.25e-06	7.76e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.21e-06	7.65e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—AKT1—ovarian cancer	3.11e-06	7.41e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CB—ovarian cancer	3.06e-06	7.31e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.06e-06	7.31e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CB—ovarian cancer	3.05e-06	7.27e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.98e-06	7.11e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TYMS—ovarian cancer	2.92e-06	6.98e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.67e-06	6.37e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—AKT1—ovarian cancer	2.66e-06	6.34e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTEN—ovarian cancer	2.65e-06	6.32e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTEN—ovarian cancer	2.63e-06	6.28e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CAV1—ovarian cancer	2.36e-06	5.62e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTEN—ovarian cancer	2.31e-06	5.5e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.15e-06	5.12e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.89e-06	4.5e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.87e-06	4.46e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CA—ovarian cancer	1.86e-06	4.43e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.65e-06	3.92e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.63e-06	3.88e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AKT1—ovarian cancer	1.53e-06	3.64e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AKT1—ovarian cancer	1.52e-06	3.62e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTEN—ovarian cancer	1.42e-06	3.39e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AKT1—ovarian cancer	1.33e-06	3.17e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1e-06	2.39e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AKT1—ovarian cancer	8.19e-07	1.95e-05	CbGpPWpGaD
